Navigation Links
Idenix to Host Conference Call Discussing Second Quarter and Six Month 2011 Financial Results
Date:7/21/2011

CAMBRIDGE, Mass., July 21, 2011 /PRNewswire/ -- Idenix Pharmaceuticals, Inc., (NASDAQ: IDIX) announced today that it will report its financial results for the second quarter of 2011 on Monday, August 8, 2011 after U.S. financial markets close.

Idenix management will host a conference call at 4:30 p.m. ET on Monday, August 8, 2011 to discuss the company's financial results for the second quarter of 2011 and provide an update on the company's development programs.

To access the call please dial (800) 471-3635 U.S./Canada or (706) 758-9475 International and enter passcode 86055177. There will also be a slide presentation available to accompany the conference call, which can be accessed shortly before the start of the conference call on our website in the Idenix Investor Center at www.idenix.com.  To listen to a live webcast of the call, go to “Calendar of Events” in the Idenix Investor Center at www.idenix.com. Please log in approximately 10 minutes before the call to ensure a timely connection. A replay of the conference call and webcast will be available until August 22, 2011. To access the replay, please dial (800) 642-1687 U.S./Canada or (706) 645-9291 International and enter the passcode 86055177.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to http://www.idenix.com.

Idenix Pharmaceuticals Contacts:
Kelly Barry (617) 995-9033 (media)
Eric Hoffman (617) 224-4485 (investors)


'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Idenix to Host Conference Call Discussing Third Quarter 2008 Financial Results
2. Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results
3. Idenix Pharmaceuticals to Present at Deutsche Banks 2008 Biotech Boston Confab
4. Idenix Pharmaceuticals to Present at the JP Morgan 27th Annual Healthcare Conference
5. Idenix to Host Conference Call Discussing Fourth Quarter 2008 Financial Results
6. Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results
7. Idenix Announces Data Presentations from Three HCV Discovery and Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL)
8. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
9. Idenix Pharmaceuticals Reports Data From Three Hepatitis C Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver
10. Idenix Pharmaceuticals Reports First Quarter Financial Results
11. Idenix Pharmaceuticals to Present at The Deutsche Bank 2009 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... USA (PRWEB) , ... August 20, 2017 , ... ... the Journal of Biomedical Optics (JBO) starting 1 January 2018. The journal is ... of Biomedical Optics publishes papers on the use of modern optical technology for ...
(Date:8/21/2017)... ... August 21, 2017 , ... MacArthur Sotheby’s ... Hawaii, is pleased to announce the first Delos Wellness Signature™ residence in Hawaii ... Realty is working together with listing agent Kelly Allen, R(S) of Carvill Sotheby’s ...
(Date:8/21/2017)... ... August 21, 2017 , ... Finalists have recently been ... centers that have implemented innovative products, services, and technology over the past year. ... financial impact/value, and market need. The applicants with the top three scores in ...
(Date:8/21/2017)... ... August 21, 2017 , ... Baltimore biotech firm, PathSensors, Inc., ... bring its proprietary CANARY pathogen detection technology and high throughput testing solutions to ... purchased an undisclosed number of PathSensors’ Zephyr pathogen detection instruments and will act ...
Breaking Biology Technology:
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
(Date:3/27/2017)... March 27, 2017  Catholic Health Services (CHS) ... Systems Society (HIMSS) Analytics for achieving Stage 6 ... sm . In addition, CHS previously earned a ... using an electronic medical record (EMR). ... level of EMR usage in an outpatient setting.  ...
Breaking Biology News(10 mins):